June 2012 | OncologyLive

High Points and Hurdles: Immunotherapy Moves Forward

June 27, 2012

Immunotherapy is maintaining its momentum in clinical development programs, with explorations under way in many tumor types, including breast and lung cancers previously considered poor candidates for such modalities.